Research Paper Volume 15, Issue 24 pp 15134—15160
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer
Figure 1. COL10A1 expression in different cancers. Differential expression analysis of COL10A1 between tumor and normal groups in 33 cancers (A). Mean expression of COL10A1 in 33 cancers (from high to low) (B). Pan-cancer expression profile of COL10A1 from the TIMER database (C).